These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2425953

  • 1. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S, Ujjani B, Renner K, Antholine W, Petering DH, Whetstone JW, Knight JM.
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes.
    Rao EA, Saryan LA, Antholine WE, Petering DH.
    J Med Chem; 1980 Dec; 23(12):1310-8. PubMed ID: 6161253
    [Abstract] [Full Text] [Related]

  • 3. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins.
    Byrnes RW, Templin J, Sem D, Lyman S, Petering DH.
    Cancer Res; 1990 Sep 01; 50(17):5275-86. PubMed ID: 1696848
    [Abstract] [Full Text] [Related]

  • 4. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K, Zwelling LA, Lown JW, Hartley JA, Nishikawa K, Lin JR, Newman RA.
    Cancer Res; 1990 Mar 15; 50(6):1732-7. PubMed ID: 1689610
    [Abstract] [Full Text] [Related]

  • 5. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS, Braun ID, Meandzija B, Kennedy KA, Pham ET, Smaldone LF.
    Cancer Res; 1985 May 15; 45(5):2103-9. PubMed ID: 2580616
    [Abstract] [Full Text] [Related]

  • 6. The relationship among transport, intracellular binding, and inhibition of RNA synthesis by actinomycin D in Ehrlich ascites tumor cells in vitro.
    Bowen D, Goldman ID.
    Cancer Res; 1975 Nov 15; 35(11 Pt 1):3054-60. PubMed ID: 1182700
    [Abstract] [Full Text] [Related]

  • 7. Studies on the chemical reactivity of copper bleomycin.
    Antholine WE, Solaiman D, Saryan LA, Petering DH.
    J Inorg Biochem; 1982 Oct 15; 17(2):75-94. PubMed ID: 6184448
    [Abstract] [Full Text] [Related]

  • 8. DNA cleavages of bleomycin-transition metal complexes induced by reductant, hydrogen peroxide, and ultraviolet light: characteristics and biological implication.
    Suzuki T, Kuwahara J, Sugiura Y.
    Nucleic Acids Symp Ser; 1984 Oct 15; (15):161-4. PubMed ID: 6084237
    [Abstract] [Full Text] [Related]

  • 9. Fe- and Co-bleomycins bound to site specific and nonspecific DNA decamers: comparative binding and reactivity of their metal centers.
    Fulmer P, Zhao C, Li W, DeRose E, Antholine WE, Petering DH.
    Biochemistry; 1997 Apr 08; 36(14):4367-74. PubMed ID: 9100034
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the association of radiolabeled bleomycin A2 with HeLa cells.
    Roy SN, Horwitz SB.
    Cancer Res; 1984 Apr 08; 44(4):1541-6. PubMed ID: 6200212
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS, Braun ID, Labaree DC, Schisselbauer JC, Meandzija B, Newman RA, Kennedy KA.
    Cancer Res; 1989 Jan 01; 49(1):185-90. PubMed ID: 2461797
    [Abstract] [Full Text] [Related]

  • 12. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
    Mahmutoglu I, Kappus H.
    Mol Pharmacol; 1988 Oct 01; 34(4):578-83. PubMed ID: 2459594
    [Abstract] [Full Text] [Related]

  • 13. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
    Stoehr M, Friedel G, Engel P, Goerttler K, Futterman G.
    Arzneimittelforschung; 1984 Oct 01; 34(4):451-4. PubMed ID: 6204650
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary fate of [3H]bleomycin A2 in mice.
    Lazo JS, Pham ET.
    J Pharmacol Exp Ther; 1984 Jan 01; 228(1):13-8. PubMed ID: 6198509
    [Abstract] [Full Text] [Related]

  • 15. [The effect of bleomycin on brain tumor cells in vitro (author's transl)].
    Harada K, Kajikawa H, Harada Y, Okada T.
    No Shinkei Geka; 1975 Nov 10; 3(11):909-15. PubMed ID: 55988
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycin.
    Stern PH, Helpern SE, Hagan PL, Howell SB, Dabbs JE, Gordon RM.
    J Natl Cancer Inst; 1981 May 10; 66(5):807-11. PubMed ID: 6164811
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of cytotoxicity of bleomycin by dithiocarbamates: formation of bis(dithiocarbamato) cu(II).
    Ujjani B, Lyman S, Winkelmann D, Antholine W, Petering DH, Jones MM.
    J Inorg Biochem; 1990 Jan 10; 38(1):81-93. PubMed ID: 1692085
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.
    Yalowich JC, Goldman ID.
    Cancer Res; 1984 Mar 10; 44(3):984-9. PubMed ID: 6692420
    [Abstract] [Full Text] [Related]

  • 19. Uptake of main fractions of labelled bleomycin by solid Ehrlich ascites tumours in mice.
    Rembelska M, Liniecki J, Koniarek B, Krawczyk Z.
    Nuklearmedizin; 1984 Jun 10; 23(3):127-9. PubMed ID: 6207486
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of bleomycin cytotoxicity by polyhydric alcohols.
    Suzuki T, Kohda K, Kawazoe Y.
    Anticancer Res; 1990 Jun 10; 10(1):97-103. PubMed ID: 1692198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.